Stryker Neurovascular
Clinical trials sponsored by Stryker Neurovascular, explained in plain language.
-
Doctors track 500 patients for 8 years to see if brain aneurysm device holds up
Disease control OngoingThis study is checking the long-term safety and performance of a medical device called the Surpass Evolve Flow Diverter, which is already approved and used to treat brain aneurysms. It will follow 500 patients for up to 8 years to see if the device successfully blocks off the ane…
Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New device aims to seal off dangerous brain bulges
Disease control OngoingThis study is testing a new medical device called the Citadel Embolization Device. It is designed to block off blood flow to a specific type of dangerous brain aneurysm, preventing it from rupturing and causing a stroke. The study will follow 150 patients for a year to see how sa…
Phase: NA • Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC